AVITA Medical, Inc. — Investor Relations & Filings

AVITA Medical, Inc. is a regenerative medicine company focused on developing and commercializing therapeutic solutions for wound care and skin restoration. The company's core technology is the proprietary RECELL System, a point-of-care device that enables clinicians to create a suspension of Spray-On Skin™ Cells using a small sample of the patient's own skin. This autologous cell harvesting technology is designed to treat thermal burn wounds and full-thickness skin defects. The RECELL System, including its latest iteration RECELL GO, is approved by the FDA and aims to optimize the healing process and accelerate patient recovery. In addition to its primary platform, AVITA Medical also markets and distributes other wound care products, such as the PermeaDerm biosynthetic wound matrix and the Cohealyx collagen-based dermal matrix, in the United States. The company continues to explore the application of its technology for other skin-related indications.